“AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability”. 2026. Explore Medical Science and Global Health 3 (October): 38-47. https://doi.org/10.70267/emsgh.v3.3847.